Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Chylothorax

Respiratory · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

A large or rapidly accumulating chylothorax can cause severe breathlessness and hypoxaemia; postoperative output may also signal a substantial ongoing thoracic-duct injury. Stabilise breathing, use thoracic ultrasound, drain when clinically necessary through a pleural-capable team, quantify the loss and involve thoracic surgery, interventional radiology and specialist nutrition early. Do not wait for the fluid to look milky before acting on respiratory compromise.

Synopsis

Confirm pleural chyle biochemically, distinguish it from pseudochylothorax, find traumatic or non-traumatic causes, protect nutrition and immunity, and escalate a persistent leak to specialist lymphatic intervention.

  • Chylothorax is lymph rich in chylomicrons entering the pleural space after disruption or obstruction of the thoracic lymphatic system; appearance alone cannot confirm it.
  • Pleural fluid triglyceride above 1.24 mmol/L supports chylothorax, and demonstration of chylomicrons by lipoprotein analysis is the reference test when biochemical results are equivocal.
  • Pseudochylothorax develops in a longstanding effusion, commonly with tuberculosis or rheumatoid pleuritis, and is characterised by high cholesterol, cholesterol crystals and absent chylomicrons.
  • Recent oesophageal, mediastinal, cardiac or neck surgery and thoracic trauma point to duct injury; without trauma, search particularly for lymphoma, other malignancy, central venous obstruction and lymphatic disease.
  • Measure drain output and nutritional consequences rather than repeatedly discarding fluid without a plan; ongoing chyle loss depletes calories, fat, fat-soluble vitamins, lymphocytes and immunoglobulins.
  • A specialist dietitian may use a low-long-chain-fat diet with medium-chain triglyceride supplementation, enteral modification or parenteral nutrition according to leak severity and the patient's wider needs.
  • Treat the driver as well as the collection: oncological therapy, relief of venous obstruction or management of lymphangioleiomyomatosis can be as important as pleural drainage.
  • Persistent or clinically important leakage should be discussed for lymphatic imaging, thoracic-duct embolisation or surgical ligation; availability, timing and thresholds vary between expert centres.

Key red flags

Postoperative leak

New pleural drainage that increases or becomes creamy after enteral feeding following oesophagectomy, mediastinal surgery, cardiac surgery or neck dissection is highly suggestive. Record the operation, side, daily volume and relation to feeding.

Respiratory compromise

Tachypnoea, hypoxaemia, inability to lie flat or mediastinal displacement from a large collection requires urgent ultrasound-guided therapeutic drainage assessment, irrespective of whether lipid testing has returned.

Investigation priorities

01
Thoracic ultrasound and chest imagingFirst step

Confirm a safely accessible effusion, identify septation and guide sampling or drainage.

Management branches

ConfirmProve chyle and define the cause

Milky fluid, an unexplained lymphocytic effusion or new output after thoracic or neck surgery.

  1. Use thoracic ultrasound for aspiration, send triglyceride and cholesterol, and request chylomicron analysis when the biochemical pattern is borderline or clinical suspicion remains high.
  2. Build a timeline around surgery, trauma, feeding and central venous access; examine for lymphadenopathy and review for lymphoma, other cancer, venous thrombosis, cirrhosis, tuberculosis and lymphatic disorders.
  3. Obtain contrast-enhanced cross-sectional imaging unless the postoperative anatomy and immediate management are already clear, then discuss unexplained cases with a specialist pleural and lymphatic MDT.
ConserveReduce flow without causing depletion

The patient is stable and a time-limited conservative trial is clinically reasonable.

  1. Drain only for symptoms or as required by the postoperative plan, and chart the true daily volume with oral or enteral intake so response can be judged meaningfully.
  2. Ask a specialist dietitian to choose a low-long-chain-fat, medium-chain-triglyceride-enriched approach or temporary alternative nutrition; do not improvise a prolonged fat-free diet.

Key medicines

Octreotide as an adjunct in selected chyle leaksThere is no nationally standard adult chylothorax regimen. If used, prescribe an expert-centre protocol with pharmacy review and a documented output-based stop rule; use is off-label.Evidence is limited and it must not delay embolisation or surgery when loss persists. Monitor glucose, gastrointestinal effects, gallbladder risk, pulse and relevant interactions; dosing varies with route, organ function and local experience.
Open full textbook →Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • BTS Pleural Disease Guideline Appendix 1UK pleural-fluid triglyceride, cholesterol and chylomicron framework with chylothorax and pseudochylothorax causes.
  • BTS Clinical Statement on pleural proceduresNational procedural-safety principles for ultrasound-guided aspiration and drain care.
  • NICE IPG755: Thoracic duct embolisationCurrent UK interventional-procedure governance for a persistent chyle leak.
  • ERS Breathe review: Non-traumatic chylothoraxSpecialist-society diagnostic, nutritional, lymphatic-imaging and escalation synthesis for uncommon non-traumatic disease.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
Replace fluid and micronutrient deficits according to measured need, treat the underlying disorder and review progress frequently against agreed output, respiratory and nutritional endpoints.